Evidence map›Paper›PMID 20945976›Full record

ArticleJournal of receptor and signal transduction research2010

A discrete affinity-driven elevation of ZAP-70 kinase activity initiates negative selection.

Michel Mallaun, Gerhard Zenke, Ed Palmer

Open access · greenAbstract read
In one paragraph

Article in Journal of receptor and signal transduction research, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.3field-weighted citation impact, top 37% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Signaling in thymic selection.Current opinion in immunology · 2011
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Michel MallaunLaboratory of Transplantation Immunology and Nephrology, Department of Biomedicine, University Hospital Basel, Basel, Switzerland.
Gerhard Zenke
Ed Palmer
University Hospital of Basel · CHNovartis (Switzerland) · CH

Funding

Soluble T Cel Receptor Studies on MHC RestrictionR01AI074074 · NIAID · SCRIPPS RESEARCH INSTITUTE, THE · PI GASCOIGNE, NICHOLAS R · 2007 to 2011
$2.2M
NIAID NIH HHS AI074074NIAID NIH HHS R01 AI074074
6 · The paper itself

Abstract

contextAlthough ZAP-70 is required for T-cell development, it's unclear how this kinase controls both positive and negative selection. OBJECTIVE AND

methodsUsing OT-I pre-selection thymocytes and a panel of peptide major histocompatibility complex (pMHC) ligands of defined affinity, the recruitment, phosphorylation and activity of ZAP-70 was determined at the interface with antigen-presenting cells (APCs).

resultspMHC ligands promoting negative selection induce a discrete elevation of ZAP-70 recruitment, phosphorylation and enzymatic activity in the thymocyte:APCs interface. DISCUSSION: The quantity of ZAP-70 kinase activity per cell is a key parameter controlling the fate of a developing thymocyte since partial inhibition of ZAP-70 kinase activity converted negative into positive selection. Surprisingly, the amount of ZAP-70 enzymatic activity observed during negative selection is not controlled by differential phosphorylation of the ZAP-70 protein but rather by the total amount of T-cell receptor and co-associated ZAP-70 recruited to the thymocyte:APC interface.

conclusionsThese data provide evidence that a burst of ZAP-70 activity initiates the signaling pathways for negative selection.

Indexed as

AnimalsAntigen-Presenting CellsLigandsLymphocyte ActivationMajor Histocompatibility ComplexMiceMice, Inbred C57BLMice, KnockoutReceptors, Antigen, T-CellSignal TransductionT-LymphocytesZAP-70 Protein-Tyrosine KinaseLigandsReceptors, Antigen, T-CellZAP-70 Protein-Tyrosine Kinase

Identifiers

PMID20945976
PMCPMC3056388
OpenAlexW2167481205

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.